Kathad, Umesh
Kulkarni, Aditya
McDermott, Joseph Ryan
Wegner, Jordan
Carr, Peter
Biyani, Neha
Modali, Rama
Richard, Jean-Philippe
Sharma, Panna
Bhatia, Kishor
Article History
Received: 25 November 2020
Accepted: 15 February 2021
First Online: 2 March 2021
Declarations
:
: Not applicable.
: Not applicable.
: Financial competing interests: U.K., A.K., J.R.M., J.W., N.B., P.S. and K.B. are or have been salaried employees of or consultants to the pharmaceutical company Lantern Pharma Inc. U.K., A.K., P.S., and K.B. hold options to purchase common stock of Lantern Pharma Inc. and are also included as inventors on patent applications filed by Lantern Pharma Inc. J.-P.R. and R.M. are employees of REPROCELL USA, Inc., a commercial contract research organization providing services to Lantern Pharma Inc. Non-financial competing interests: The authors declare that they have no competing interests.